2 Million Fisher-Price Infant Swings Recalled After 5 Deaths

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 11, 2024.

By Ernie Mundell HealthDay Reporter

FRIDAY, Oct. 10, 2024 -- The Fisher-Price company is recalling more than 2 million of its Snuga infant swings, after the suffocation and deaths of five infants who went to sleep while in the swings.

"The swing should never be used for sleep and bedding materials should never be added to it," according to an alert from the U.S. Consumer Product Safety Commission, which announced the recall.

"If the product is used for sleep or bedding material is added, the headrest and body support insert on the seat pad can increase the risk of suffocation," the agency explained.

The CPSC's advice to parents who already have one of the Snuga infant swings at home: "Consumers should immediately remove both the headrest (by cutting the tether) and the body support insert from the seat pad before continuing to use the swing for awake-time activities."

A full list of the 21 recalled Fisher-Price infant swing models, with photos, can be found at the CPSC.

As the agency explained, five reported deaths of infants between one and three months of age were linked to use of Snuga swings between 2012 and 2022.

"In most of those incidents, the infants were unrestrained and bedding materials were added to the product," the CPSC noted.

Besides the danger from the Fisher-Price products under recall, the agency reminded parents and caregivers that they "should never use any inclined seated products, such as swings, gliders, soothers, and rockers, for infant sleep and should not leave infants in these products unsupervised, unrestrained, or with bedding material due to the risk of suffocation."

Instead, always lay an infant flat on their back for sleep "on a firm, flat surface in a crib, bassinet, or play yard, with nothing but a fitted sheet," the CPSC advised.

The agency noted that in 2022, Congress banned the sale of any form of inclined sleeper for infants.

Sources

  • Consumer Product Safety Commission, announcement, Oct. 10, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-12 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords